Gilde Healthcare
Capital Type
Venture Capital
Investment Size
Undisclosed / varies by deal
Geographic Scope
Europe, US, Global
Return Model
Dilutive
Stage Focus
Growth, Late Venture
Modality Focus
Diagnostics, Infectious disease
Overview
Healthcare investor active in growth and later-stage company building across therapeutics, medtech, and diagnostics.
Portfolio and Signals
AMR relevance is strongest through infectious-disease diagnostics exposure such as Karius and related precision microbiology themes.
Access and Engagement
Standard venture access; best fit is for companies with clear commercial pathways and differentiated clinical utility.
Notable AMR Examples / Programs
Karius
Stay Updated
Stay connected so that you don't miss the latest AMR insights and updates.
